The ROE as of September 2024 (TTM) for Rhythm Pharmaceuticals, Inc. (RYTM) is -221.66%

According to Rhythm Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -221.66%. This represents a change of 147.35% compared to the average of -89.61% of the last 4 quarters.

Rhythm Pharmaceuticals, Inc. (RYTM) Historical ROE (quarterly & annually)

How has RYTM ROE performed in the past?

The mean historical ROE of Rhythm Pharmaceuticals, Inc. over the last ten years is 104.28%. The current -221.66% ROE has changed -312.57% with respect to the historical average. Over the past ten years (40 quarters), RYTM's ROE was at its highest in in the March 2015 quarter at 224.57%. The ROE was at its lowest in in the March 2024 quarter at -229.57%.

Rhythm Pharmaceuticals, Inc. (RYTM) ROE by Quarter and Year

Discovering the peaks and valleys of Rhythm Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rhythm Pharmaceuticals, Inc. (RYTM) Average ROE

How has RYTM ROE performed in the past?

The current ROE of Rhythm Pharmaceuticals, Inc. (RYTM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Rhythm Pharmaceuticals, Inc. (RYTM) ROE vs. Peers

How is RYTM’s ROE compared to its peers?

Rhythm Pharmaceuticals, Inc.’s ROE is greater than Revolution Medicines, Inc. (-34.57%), greater than Akero Therapeutics, Inc. (-29.56%), greater than Avidity Biosciences, Inc. (-32.89%), less than Protagonist Therapeutics, Inc. (85.47%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than uniQure N.V. (-158.09%), greater than Rocket Pharmaceuticals, Inc. (-54.47%), greater than Solid Biosciences Inc. (-53.76%), greater than MeiraGTx Holdings plc (-86.28%), greater than Nuvalent, Inc. (-28.83%), greater than Ventyx Biosciences, Inc. (-61.43%), greater than Arcellx, Inc. (-12.42%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Kiniksa Pharmaceuticals, Ltd. (-5.10%), greater than Pliant Therapeutics, Inc. (-41.05%), greater than Syndax Pharmaceuticals, Inc. (-57.42%), greater than Viridian Therapeutics, Inc. (-49.65%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Relay Therapeutics, Inc. (-43.66%), greater than Black Diamond Therapeutics, Inc. (-69.08%), greater than Arvinas, Inc. (-55.59%),

Build a custom stock screener for Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhythm Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rhythm Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.